A Clinical Trial of Tolcapone in Obsessive Compulsive Disorder

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 22, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions

Obsessive-Compulsive DisorderOCD

Interventions

DRUG

Tolcapone

catechol-O-methyl transferase inhibitor

DRUG

Placebo

Pill that contains no medicine

Trial Locations (1)

RECRUITING

University of Chicago Medical Center, Chicago

All Listed Sponsors

lead

University of Chicago

OTHER